Seta Shahin
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 2
- Oncology 10
- Neutropenia and Cancer Infections 7
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Tarek ChidiacJohn L. MarshallRafael G. AmadoAllen Lee CohnDavid R. SpigelDavid McCollumJ. Randolph HechtChristopher Hagenstad
- Journals
- Journal of Clinical Oncology (4 papers)Clinical Cancer Research (1 paper)Breast Cancer Research and Treatment (1 paper)Therapeutic Innovation & Regulatory Science (1 paper)Statistics in Biopharmaceutical Research (1 paper)
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
Seta Shahin
13 papers receiving 916 citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Oncology 812
- Hepatology 186
- Pulmonary and Respiratory Medicine 319
- Cancer Research 127
- Pathology and Forensic Medicine 145
Countries citing papers authored by Seta Shahin
This map shows the geographic impact of Seta Shahin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seta Shahin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seta Shahin more than expected).
Fields of papers citing papers by Seta Shahin
This network shows the impact of papers produced by Seta Shahin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seta Shahin. The network helps show where Seta Shahin may publish in the future.
Co-authors
The 25 scholars most cited alongside Seta Shahin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 2 | |
| 2 | 2019 | 1 | |
| 3 | 2019 | 14 | |
| 4 | 2015 | 12 | |
| 5 | 2010 | 74 | |
| 6 | A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 644 |
| 7 | 2007 | 98 | |
| 8 | 2006 | 16 | |
| 9 | 2006 | 7 | |
| 10 | 2005 | 2 | |
| 11 | 2005 | 5 | |
| 12 | Randomized double-blind phase 2 study evaluating sameday vs next-day administration of pegfilgrastim with docetaxel, doxorubicin, and cyclophosphamide (tac) in women with early stage and advanced breast cancer | 2004 | 12 |
| 13 | 2002 | 61 |
About Seta Shahin
Seta Shahin is a scholar working on Toxicology, Oncology, Statistics and Probability, Genetics and Hematology, having authored 13 papers that have together received 948 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (7 papers), Cancer Treatment and Pharmacology (3 papers), Blood disorders and treatments (3 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Oncology (812 citations), Hepatology (186 citations), Pulmonary and Respiratory Medicine (319 citations), Cancer Research (127 citations) and Pathology and Forensic Medicine (145 citations). Seta Shahin has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Tarek Chidiac, John L. Marshall, Rafael G. Amado, Allen Lee Cohn, David R. Spigel, David McCollum, J. Randolph Hecht, Christopher Hagenstad, Robert G Deeter and Edith P. Mitchell. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Breast Cancer Research and Treatment, Therapeutic Innovation & Regulatory Science and Statistics in Biopharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.